The Preferred Treatment for Stage I Seminoma: A Survey of Canadian Radiation Oncologists

• Published in: Clinical oncology (Royal College of Radiologists (Great Britain)) Vol. 18; no. 9; pp. 696 - 699
• Main Authors: Alomary, I., Samant, R., Genest, P., Eapen, L., Gallant, V.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.11.2006
• Subjects: Canada; Chemotherapy, Adjuvant - statistics & numerical data; Health Care Surveys; Humans; Male; Neoplasm Staging; Orchiectomy - statistics & numerical data; practice pattern; Radiation Oncology - statistics & numerical data; radiotherapy; Radiotherapy, Adjuvant - statistics & numerical data; seminoma; Seminoma - pathology; Seminoma - therapy; surveillance; Surveys and Questionnaires; Testicular Neoplasms - pathology; Testicular Neoplasms - therapy; Canada; radiotherapy; Canada; seminoma; surveillance; practice pattern
• ISSN: 0936-6555; 1433-2981
• DOI: 10.1016/j.clon.2006.06.008

To evaluate the preferences of radiation oncologists for managing stage I seminoma. An electronic survey evaluating the management of stage I seminoma patients was sent to Canadian radiation oncologists to determine their treatment recommendations and preferences. The survey completion rate was 74% among eligible respondents (78/105). Most (56%) felt that surveillance was the preferred treatment for patients, whereas 31% thought that adjuvant radiotherapy was best, 1% chose adjuvant chemotherapy as being the preferred option and 12% were unsure. Most would choose the same treatment for themselves if they were diagnosed with stage I seminoma. A previously published survey found that most respondents considered radiotherapy as the best option. Most Canadian radiation oncologists now favour surveillance for most stage I seminoma patients.